| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.03 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |